`
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________________________
`Aurobindo Pharma USA Inc.
`Petitioners,
`v.
`Andrx Labs, LLC
`Patent Owner
`____________________________________________
`Case IPR2017-01648
`U.S. Patent No. 6,866,866
`____________________________________________
`
`PATENT OWNER’S OBJECTIONS TO EVIDENCE
`PURSUANT TO 37 C.F.R. § 42.64
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`Pursuant to 37 C.F.R. § 42.64, Patent Owner Andrx Labs (“Andrx”) presents
`
`the following objections to evidence served with the Corrected Petition of
`
`Aurobindo (“Aurobindo” or “Petitioner”), Paper No. 8.
`
`I.
`
`Exhibits 1004, 1005, 1008, 1009, 1011-1018
`Patent Owner objects to Exhibits 1004-1005, 1008-1009, and 1011-1018,
`
`which are not cited in the Petition, or in any paragraph of the Akhlaghi Declaration
`
`that is cited to by the Petition, and are impermissibly incorporated by reference.
`
`See Fed. R. Evid. 401, 402, 403; 37 C.F.R. § 42.6(a)(3).
`
`II. Exhibit 1006
`Patent Owner objects to Exhibit 1006, Sciele Pharma Inc. v. Lupin Ltd., No.
`
`2012-1228 (Fed. Cir. July 2, 2012) (slip op.). Specifically, Patent Owner objects to
`
`the relevance and probative value of Exhibit 1006, in light of the potential for
`
`undue prejudice and confusion of the issues. See Fed. R. Evid. 401, 402, 403.
`
`III. Exhibit 1007
`Patent Owner objects to Exhibit 1007, WO 00/12097 (“Chen et al.”).
`
`Specifically, Patent Owner objects to the relevance and probative value of Exhibit
`
`1007, in light of the potential for undue prejudice and confusion of the issues. See
`
`Fed. R. Evid. 401, 402, 403, 901. As the Board determined in its Institution
`
`Decision, Paper No. 12 at 10, the Petition did not demonstrate that Exhibit 1007
`
`1
`
`
`
`
`
`
`qualifies as prior art to the ’866 patent, and accordingly this Exhibit forms no part
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`
`
`
`of the ground on which inter partes review was instituted.
`
`IV. Exhibit 1019
`Patent Owner objects to Exhibit 1019, Declaration of Dr. Fatemeh Akhlaghi.
`
`Patent Owner objects to ¶¶ 12-25, 27-30, 32-90, 97, 99-131, 133-134, 136-
`
`143, 145-147, 150-154, 156-166, 168-169, 171-172, 174-175, 178-182, 184-191,
`
`193-194, and 196-204. These paragraphs are not directly cited in the Petition and
`
`the relevance of these paragraphs is not apparent. Patent Owner objects to the
`
`blanket citation in the Petition to paragraphs 197-204 as comprising an
`
`impermissible incorporation by reference of a declaration. See
`
`37 C.F.R. § 42.6(a)(3). Patent Owner further objects to the citation in the Petition
`
`to purported Appendix XIII of Exhibit 1019 (Paper No. 8 at 13). First, Exhibit
`
`1019 does not include an Appendix XIII. Even presuming the Petition attempted
`
`to cite to Appendix XII of Exhibit 1019, this citation does not describe the
`
`relevance of that Appendix with sufficient specificity.
`
`Patent Owner objects to ¶¶ 15, 17, 19, 23-24, 26, 31, 61, 66, 71, 73, 74, 127,
`
`144, 156, 158, 160, 162-165, 174, 182, 184, 191, 203, heading IX(A)(1), IX(A)(2),
`
`heading IX(A)(3), heading IX(B)(1), the heading labeled “C.” (appearing after
`
`heading IX(B)(1)), heading IX(C), and heading X as testimony on a topic
`
`2
`
`
`
`
`
`
`(including legal conclusions and interpretations) on which the declarant is not
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`
`
`
`qualified to opine. See Fed. R. Evid. 702, 703.
`
`Patent Owner objects to ¶¶ 10, 15, 26, 31, 36-51, 54-65, 125-135, 137-139,
`
`142-144, 145, 147, 168-173, 175, 177-179, 185, 190, heading IX(A)(1) and
`
`heading IX(B)(1), which contain citations to Exhibits that are not cited in the
`
`Petition, and/or that form no part of the ground on which inter partes review was
`
`instituted, as irrelevant. See Fed. R. Evid. 402. All of the portions of the Akhlaghi
`
`Declaration objected to in this paragraph are impermissibly incorporated by
`
`reference and therefore objectionable. See Fed. R. Evid. 402;
`
`37 C.F.R. § 42.6(a)(3).
`
`Respectfully Submitted,
`
`Date: January 16, 2018
`
`/David L. Cavanaugh/
`
`David L. Cavanaugh
`Registration No. 36,476
`1875 Pennsylvania Avenue NW
`Washington, DC 20006
`(202) 663-6025
`
`
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on January 16, 2018, I caused a true and correct copy of the
`
`foregoing materials:
`
`
`
`•
`
`Patent Owner’s Objections to Evidence
`
`to be served via electronic mail on the following attorney of record for Petitioner:
`
`Steven J. Moore, Esq.
`Withers Bergman LLP
`Suite 400
`1700 East Putnam Avenue
`Greenwich, CT 06870
`steven.moore@withersworldwide.com
`John Winterle
`Withers Bergman LLP
`Suite 400
`1700 East Putnam Avenue
`Old Greenwich, CT 06870
`john.winterle@withersworldwide.com
`
`Hans Peter Hoffmann
`Withers Bergman
`Suite 400
`1700 East Putnam Avenue
`Old Greenwich, CT 06870
`peter.hoffmann@withersworldwide.com
`
`Alan Gardner
`Withers Bergman
`Suite 400
`1700 East Putnam Avenue
`Old Greenwich, CT 06870
`alan.gardner@withersworldwide.com
`
`IPG-AUR@withersworldwide.com
`
`4
`
`
`
`
`
`
`
`
`
`
`IPR2017-01648
`U.S. Patent No. 6,866,866
`
`
`
`
`
`
`__/Jonathan Ben-Ur Roses/__
`Jonathan B. Roses
`Reg. No. 61,115
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`617-526-6048
`
`5
`
`